XKRX:299660 (Korea (the Republic of))
Â
Ordinary Shares
â‚©
3,350
+10 (+0.3%)
Apr 11
What is a stock summary page? Click here for an overview.
Business Description
Cellid Co Ltd
ISIN : KR7299660001
Share Class Description:
XKRX:299660: Ordinary SharesCompare
Compare
Traded in other countries / regions
299660.Korea Index Membership
KOSDAQ Composite Index IPO Date
2019-02-20Description
Cellid Co Ltd is a research and development bioventure company. The company is developing immunotherapeutic vaccines, CeliVax. The CeliVax is a personalized vaccine which uses patient's own cells.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.69 | |||||
| Equity-to-Asset | 0.67 | |||||
| Debt-to-Equity | 0.26 | |||||
| Debt-to-EBITDA | -1.44 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 0.01 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 45.6 | |||||
| 3-Year EBITDA Growth Rate | 15.9 | |||||
| 3-Year EPS without NRI Growth Rate | 14.2 | |||||
| 3-Year FCF Growth Rate | -19.6 | |||||
| 3-Year Book Growth Rate | -11.3 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 50.9 | |||||
| 9-Day RSI | 42.18 | |||||
| 14-Day RSI | 38.53 | |||||
| 3-1 Month Momentum % | -28.57 | |||||
| 6-1 Month Momentum % | -21.05 | |||||
| 12-1 Month Momentum % | 1.89 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.32 | |||||
| Quick Ratio | 2.2 | |||||
| Cash Ratio | 1.83 | |||||
| Days Inventory | 29.81 | |||||
| Days Sales Outstanding | 24.81 | |||||
| Days Payable | 26.8 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -23.7 | |||||
| Shareholder Yield % | -37.82 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 16.93 | |||||
| Operating Margin % | -287.64 | |||||
| Net Margin % | -294.33 | |||||
| FCF Margin % | -689.79 | |||||
| ROE % | -28.07 | |||||
| ROA % | -18.51 | |||||
| ROIC % | -20.54 | |||||
| 3-Year ROIIC % | 3.78 | |||||
| ROC (Joel Greenblatt) % | -27.78 | |||||
| ROCE % | -19.7 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 14.32 | |||||
| PB Ratio | 1.38 | |||||
| Price-to-Tangible-Book | 2.22 | |||||
| EV-to-EBIT | -6.35 | |||||
| EV-to-EBITDA | -8.17 | |||||
| EV-to-Revenue | 17.96 | |||||
| EV-to-FCF | -2.39 | |||||
| Earnings Yield (Greenblatt) % | -15.75 | |||||
| FCF Yield % | -40.64 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Cellid Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 4,165.093 | ||
| EPS (TTM) (â‚©) | -754 | ||
| Beta | 1.2 | ||
| 3-Year Sharpe Ratio | -0.44 | ||
| 3-Year Sortino Ratio | -0.78 | ||
| Volatility % | 133.86 | ||
| 14-Day RSI | 38.53 | ||
| 14-Day ATR (â‚©) | 240.156722 | ||
| 20-Day SMA (â‚©) | 3514.25 | ||
| 12-1 Month Momentum % | 1.89 | ||
| 52-Week Range (â‚©) | 1733 - 17310 | ||
| Shares Outstanding (Mil) | 21.1 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Cellid Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Cellid Co Ltd Stock Events
| Event | Date | Price (â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
Cellid Co Ltd Frequently Asked Questions
What is Cellid Co Ltd(XKRX:299660)'s stock price today?
The current price of XKRX:299660 is â‚©3350.00. The 52 week high of XKRX:299660 is â‚©17310.00 and 52 week low is â‚©1733.00.
When is next earnings date of Cellid Co Ltd(XKRX:299660)?
The next earnings date of Cellid Co Ltd(XKRX:299660) is .
Does Cellid Co Ltd(XKRX:299660) pay dividends? If so, how much?
Cellid Co Ltd(XKRX:299660) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers